Dr. Jean-Marc Collard is senior scientist with extensive experience in bacteriology, molecular biology and public health. After having directed 4 National Reference Centers in Belgium, he extended his expertise in Africa, where he coordinated important field and research projects in bacteriology (MenAfriCar, PAGE), antimicrobial resistance (CHARLI, BirdyI & II), on the microbiota in malnourished children (Afribiota, Malinea), including cohort studies with over 2000 children. The results of these projects were published in landmark scientific reviews such as Lancet Global Health, J Allergy Clin Immunol, CID, PNAS. As an expert in bacteriology, he collaborated with the WHO, the UNICEF, the Ministry of Health in Niger, the French Ministry of Foreign Affairs, Expertise France, the Wellcome Trust, and the Gates Foundation. During his two years at Institut Pasteur of Shanghai, he focused on the construction of the intestinal microbiota in infants. Since September 2022, he integrated the Enteric Bacterial Pathogens Unit, at the Institut Pasteur.
Click to view graph
Connections
Click to view timeline
Timeline
Projects
Former Teams
CV
Publications
Download-
2025High circulation of pertussis in infants and close contacts in Antananarivo, the capital of Madagascar in Africa, and Cambodia in Asia., BMC Infect Dis 2025 Feb; 25(1): 287.
-
2025A multicountry evaluation of the Xpert MTB/RIF assay for the diagnosis of intrathoracic tuberculosis in children using alternative specimens (nasopharyngeal aspirate and stool): A prospective cohort study conducted in Madagascar, Ivory Coast and Cameroon (TB KIDS project)., Int J Infect Dis 2025 Feb; 151(): 107366.
-
2025A multicountry evaluation of the Xpert MTB/RIF assay for the diagnosis of intrathoracic tuberculosis in children using alternative specimens (nasopharyngeal aspirate and stool): A prospective cohort study conducted in Madagascar, Ivory Coast and Cameroon (TB KIDS project), International Journal of Infectious Diseases, 2025, 151 (3), pp.107366. ⟨10.1016/j.ijid.2024.107366⟩.
-
2024Intestinal newborn regulatory B cell antibodies modulate microbiota communities., Cell Host Microbe 2024 Oct; 32(10): 1787-1804.e9.
-
2023NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway., Nat Commun 2023 Dec; 14(1): 8440.
-
2023Incidence and risk factors of neonatal bacterial infections: a community-based cohort from Madagascar (2018-2021)., BMC Infect Dis 2023 Oct; 23(1): 658.
-
2023Metagenomics revealed a correlation of gut phageome with autism spectrum disorder., Gut Pathog 2023 Aug; 15(1): 39.
-
2023One Health compartment analysis of ESBL-producing Escherichia coli reveals multiple transmission events in a rural area of Madagascar., J Antimicrob Chemother 2023 Aug; 78(8): 1848-1858.
-
2023Factors Associated with Carriage of Enteropathogenic and Non-Enteropathogenic Viruses: A Reanalysis of Matched Case-Control Data from the AFRIBIOTA Site in Antananarivo, Madagascar., Pathogens 2023 Aug; 12(8): .
-
2023Inappropriate antibiotic prescribing and its determinants among outpatient children in 3 low- and middle-income countries: A multicentric community-based cohort study., PLoS Med 2023 Jun; 20(6): e1004211.
-
+View full list of publications